Does SECUKINUMAB Cause Skin hypertrophy? 134 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Skin hypertrophy have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.
134
Reports of Skin hypertrophy with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
2
Deaths
22
Hospitalizations
How Dangerous Is Skin hypertrophy From SECUKINUMAB?
Of the 134 reports, 2 (1.5%) resulted in death, 22 (16.4%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Skin hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 134 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Skin hypertrophy?
DUPILUMAB (149)
ADALIMUMAB (105)
ETANERCEPT (48)
METHOTREXATE (42)
RITUXIMAB (41)
TACROLIMUS (40)
OMALIZUMAB (35)
PREDNISOLONE (35)
SUNITINIB MALATE (32)
RIBOCICLIB (31)
Which SECUKINUMAB Alternatives Have Lower Skin hypertrophy Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG